How to Successfully Extend the Cash Runway to Growth in Early Commercial Stage Life Science Companies
By Andrew Levitch, Patrick Nugent
This article is the second in a 4-part series reviewing financing solutions for the Life Science sector. Life Science venture capital and private equity-funded startups are constantly chasing capital to extend operating cash runways, driving value inflection milestones such as clinical trial data and funding growth for commercial-stage entities. Understandably,…Read More
Read More